首页> 外文OA文献 >Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo

【2h】

Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo

机译：免疫肿瘤剂IPI-549是癌症中p-糖蛋白（P-GP，MDR1，ABCB1）介导的多药抗性（MDR）的调节剂：体外和体内

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Albert A. De Vera; Pranav Gupta; Zining Lei; Dan Liao; Silpa Narayanan; Qiuxu Teng; Sandra E. Reznik; Zhe-Sheng Chen;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo [J] . De Vera Albert A., Gupta Pranav, Lei Zining, Cancer letters . 2019 ,第期

机译：免疫肿瘤剂IPI-549是癌症中p-糖蛋白（P-GP，MDR1，ABCB1）介导的多药抗性（MDR）的调节剂：体外和体内
2. Ixabepilone, a Novel Microtubule-Targeting Agent for Breast Cancer, Is a Substrate for P-Glycoprotein (P-gp/MDR1/ABCB1) but not Breast Cancer Resistance Protein (BCRP/ABCG2). [J] . Shen H, Lee FY, Gan J The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics . 2011 ,第2期

机译：Ixabepilone是一种新型的乳腺癌微管靶向药物，是P-糖蛋白（P-gp / MDR1 / ABCB1）的底物，但不是乳腺癌抗性蛋白（BCRP / ABCG2）的底物。
3. MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance. [J] . Lage H Current drug targets-The International journal for timely in-depth reviews on drug targets . 2006 ,第7期

机译：MDR1 / P-糖蛋白（ABCB1）作为RNA干扰介导的多药耐药性逆转的靶标。
4. MDRView: a visualization of the polymorphisms of MDR1(ABCB1) GENE in breast cancer [C] . Xhemo E., Fajac A., Boire J.-Y., Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2007

机译：MDRView：乳腺癌中MDR1（ABCB1）基因多态性的可视化
5. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells [D] . Abraham, Ioana 2012

机译：海洋海绵衍生的七环素三萜类化合物逆转癌细胞中的P-糖蛋白（ABCB1）介导的多药耐药性
6. Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells [O] . Elisabetta Teodori, Laura Braconi, Silvia Bua, 2020

机译：P-糖蛋白和CA XII双重抑制剂：逆转癌细胞中P-gp介导的多药耐药性（MDR）的新策略
7. Co-administration strategy to enhance brain accumulation of vandetanib by modulating P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp1/Abcg2) mediated efflux with m-TOR inhibitors [O] . Mukul Minocha, Varun Khurana, Bin Qin, 2012

机译：通过调节P-糖蛋白（P-GP / ABCB1）和乳腺癌抗性蛋白（BCRP1 / ABCG2）用M-TOR抑制剂的介导的介导的抗andetanib脑积累的共同施用策略

Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo

著录项

相似文献

相关主题

期刊订阅